03:49 PM EDT, 08/13/2026 (MT Newswires) -- Diagnos ( DGNOF ) said Thursday it received marketing authorization for its CARA System of AI-driven retinal image analysis from the Saudi Food and Drug Authority (SFDA).

The version of CARA licensed in Saudi Arabia includes detection algorithms for diabetic retinopathy and age-related macular degeneration, a statement said.

Diagnos ( DGNOF ) is working with a local distributor in Saudi Arabia to market the device.

The company's shares were last seen up C$0025 to C$0.41 on the TSX Venture Exchange.

Price: 0.41, Change: +0.03, Percent Change: +6.49